1Stinchcombe TE,Socinski MA. Treatment paradigms for advanced stage non-small cell lung cancer in the era of multiple lines of therapy[J].{H}JOURNAL OF THORACIC ONCOLOGY,2009,(02):243-250.
2Ciuleanu T,Brodowicz T,Zielinski C. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomised,double-blind,phase 3 study[J].{H}LANCET,2009,(9699):1432-1440.
3Scagliotti G,Brodowicz T,Shepherd FA. Treatmentby-histology interaction analyses in three phase Ⅲ trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer[J].{H}JOURNAL OF THORACIC ONCOLOGY,2011,(01):64-70.
4Mubarak N,Gaafar R,Shehata S. A randomized,phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced,non-squamous,non-small cell lung cancer[J].{H}BMC Cancer,2012,(09):423-433.
